Correction: TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer

J Exp Clin Cancer Res. 2024 Aug 29;43(1):244. doi: 10.1186/s13046-024-03170-0.

Muhlis Akman¹, Ciro Monteleone¹, Gabriella Doronzo^{1

2}, Martina Godel^{1

3}, Francesca Napoli⁴, Alessandra Merlini⁵, Virginia Campani⁶, Valeria Nele⁶, Elisa Balmas^{7

3}, Tatiana Chontorotzea⁸, Simona Fontana^{1

3}, Sabrina Digiovanni^{1

3}, Francesca Alice Barbu⁴, Elena Astanina², Niloufar Jafari^{1

3}, Iris Chiara Salaroglio^{1

3}, Joanna Kopecka^{1

3}, Giuseppe De Rosa⁶, Thomas Mohr⁸, Alessandro Bertero^{7

3}, Luisella Righi⁴, Silvia Novello⁵, Giorgio Vittorio Scagliotti⁵, Federico Bussolino^{1

2}, Chiara Riganti^{9

10}

¹ Department of Oncology, University of Torino, Torino, Italy.
² Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
³ Molecular Biotechnology Center "Guido Tarone", University of Torino, Torino, Italy.
⁴ Pathology Unit, Department of Oncology at San Luigi Hospital, University of Torino, Torino, Italy.
⁵ Thoracic Oncology Unit, Department of Oncology at San Luigi Hospital, University of Torino, Torino, Italy.
⁶ Department of Pharmacy, University of Napoli Federico II, Napoli, Italy.
⁷ Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
⁸ Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
⁹ Department of Oncology, University of Torino, Torino, Italy. [email protected].
¹⁰ Molecular Biotechnology Center "Guido Tarone", University of Torino, Torino, Italy. [email protected].

No abstract available

Publication types